Oligoclonality and new agent evaluation in acute lymphoblastic leukaemia.

about

Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics.Redefining treatment failure for pediatric acute leukemia in the era of minimal residual disease testing."The Second Time is Sweeter After All".

P2860

Q39041475-D0244A2E-FD59-429D-B450-3E81E7CB2316 Q46103668-9D2205F2-895E-4481-ACFE-71E190E03B2A Q50919950-428D1284-FF27-40D7-BC00-D658E607B879

P2860

Oligoclonality and new agent evaluation in acute lymphoblastic leukaemia.

Item

http://www.wikidata.org/entity/Q38843371

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Oligoclonality and new agent evaluation in acute lymphoblastic leukaemia.

@en

type

Item

label

Oligoclonality and new agent evaluation in acute lymphoblastic leukaemia.

@en

prefLabel

Oligoclonality and new agent evaluation in acute lymphoblastic leukaemia.

@en

P1476

Oligoclonality and new agent evaluation in acute lymphoblastic leukaemia.

@en

P2093

Weili Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Drug development: Raise standards for preclinical cancer research

Inhibitors targeting mitosis: tales of how great drugs against a promising target were brought down by a flawed rationale

Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse

United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia

The clonal evolution of tumor cell populations

Chimeric antigen receptor T cells for sustained remissions in leukemia

A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias.

Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.

Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults.

Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study.

P304

950-957

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1111/BJH.14143

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

173

http://www.w3.org/2001/XMLSchema#string

P50

Paul S. Gaynon

P577

2016-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27221005

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

Oligoclonality and new agent evaluation in acute lymphoblastic leukaemia.

about

P2860

P2860

Oligoclonality and new agent evaluation in acute lymphoblastic leukaemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921